11730 Federal Register / Vol. 87, No. 41 / Wednesday, March 2, 2022 / Notices 

C. Authority 

Section 2 of the Paperwork Reduction 

Act of 1995, 44 U.S.C. 3507. 

Colette Pollard, 

Department Reports Management Officer, 

Office of the Chief Information Officer. 

[FR Doc. 2022–04388 Filed 3–1–22; 8:45 am] 

BILLING CODE 4210–67–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 731–TA–1557 (Final)] 

Certain Mobile Access Equipment and 

Subassemblies Thereof From China; 

Supplemental Schedule for the Final 

Phase of Antidumping Duty 

Investigation 

AGENCY: United States International 

Trade Commission. 

ACTION: Notice. 

DATES: February 22, 2022. 

FOR FURTHER INFORMATION CONTACT: 

Alejandro Orozco ((202) 205–3177), 

Office of Investigations, U.S. 

International Trade Commission, 500 E 

Street SW, Washington, DC 20436. 

Hearing-impaired persons can obtain 

information on this matter by contacting 

the Commission’s TDD terminal on 202– 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at 202–205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server (https://

www.usitc.gov). The public record for 

these investigations may be viewed on 

the Commission’s electronic docket 

(EDIS) at https://edis.usitc.gov. 

SUPPLEMENTARY INFORMATION: Effective 

July 30, 2021, the Commission 

established a general schedule for the 

conduct of the final phase of its 

countervailing duty and antidumping 

duty investigations on certain mobile 

access equipment and subassemblies 

thereof (‘‘mobile access equipment’’) 

from China, following a preliminary 

determination by the U.S. Department of 

Commerce (‘‘Commerce’’) that imports 

of subject mobile access equipment from 

China were subsidized by the 

government of China (86 FR 41013, July 

30, 2021). Notice of the scheduling of 

the final phase of the Commission’s 

investigations and of a public hearing 

held in connection therewith was given 

by posting copies of the notice in the 

Office of the Secretary, U.S. 

International Trade Commission, 

Washington, DC, and by publishing the 

notice in the Federal Register on August 

12, 2021 (86 FR 44402). In light of the 

restrictions on access to the Commission 

building due to the COVID–19 

pandemic, the Commission conducted 

its hearing through written testimony 

and video conference on October 12, 

2021. All persons who requested the 

opportunity were permitted to 

participate. 

Commerce issued a final affirmative 

countervailing duty determination with 

respect to mobile access equipment 

from China (86 FR 57809, October 19, 

2021). The Commission subsequently 

issued its final determination that an 

industry in the United States is 

threatened with material injury by 

reason of imports of mobile access 

equipment from China provided for in 

subheadings 8427.10.80, 8427.20.80, 

8427.90.00, and 8431.20.00 of the 

Harmonized Tariff Schedule of the 

United States (‘‘HTSUS’’) that have been 

found by Commerce to be subsidized by 

the government of China (86 FR 70147, 

December 9, 2021). 

Commerce issued a final affirmative 

antidumping duty determination with 

respect to mobile access equipment 

from China (87 FR 9576, February 22, 

2022). Accordingly, the Commission 

currently is issuing a supplemental 

schedule for its antidumping duty 

investigation on imports of mobile 

access equipment from China. 

This supplemental schedule is as 

follows: The deadline for filing 

supplemental party comments on 

Commerce’s final antidumping duty 

determination is March 7, 2022. 

Supplemental party comments may 

address only Commerce’s final 

antidumping duty determination 

regarding imports of mobile access 

equipment from China. These 

supplemental final comments may not 

contain new factual information and 

may not exceed five (5) pages in length. 

The supplemental staff report in the 

final phase of the current investigation 

will be placed in the nonpublic record 

on March 16, 2022, and a public version 

will be issued thereafter. 

For further information concerning 

these investigations see the 

Commission’s notices cited above and 

the Commission’s Rules of Practice and 

Procedure, part 201, subparts A and B 

(19 CFR part 201), and part 207, 

subparts A and C (19 CFR part 207). 

Additional written submissions to the 

Commission, including requests 

pursuant to section 201.12 of the 

Commission’s rules, shall not be 

accepted unless good cause is shown for 

accepting such submissions, or unless 

the submission is pursuant to a specific 

request by a Commissioner or 

Commission staff. 

In accordance with sections 201.16(c) 

and 207.3 of the Commission’s rules, 

each document filed by a party to the 

investigations must be served on all 

other parties to the investigations (as 

identified by either the public or BPI 

service list), and a certificate of service 

must be timely filed. The Secretary will 

not accept a document for filing without 

a certificate of service. 

Please note the Secretary’s Office will 

accept only electronic filings during this 

time. Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https://

edis.usitc.gov). No in-person paperbased filings or paper copies of any 

electronic filings will be accepted until 

further notice. 

Authority: These investigations are 

being conducted under authority of title 

VII of the Tariff Act of 1930; this notice 

is published pursuant to section 207.21 

of the Commission’s rules. 

By order of the Commission. 

Issued: February 25, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–04396 Filed 3–1–22; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1303] 

Certain Products Containing 

Pyraclostrobin and Components 

Thereof Notice of Institution 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that a 

complaint was filed with the U.S. 

International Trade Commission on 

January 28, 2022, under section 337 of 

the Tariff Act of 1930, as amended, on 

behalf of BASF SE of Germany and 

BASF Corporation, Florham Park, New 

Jersey. A supplement to the Complaint 

was filed on February 15, 2022. The 

complaint, as supplemented, alleges 

violations of section 337 based upon the 

importation into the United States, the 

sale for importation, and the sale within 

the United States after importation of 

certain products containing 

pyraclostrobin and components thereof 

by reason of infringement of certain 

claims of U.S. Patent No. 7,816,392 

(‘‘the ’392 patent’’). The complaint 

further alleges that an industry in the 

United States exists as required by the 

applicable Federal Statute. The 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 41 / Wednesday, March 2, 2022 / Notices 11731 

complainant requests that the 

Commission institute an investigation 

and, after the investigation, issue a 

limited exclusion order and cease and 

desist orders. 

ADDRESSES: The complaint, except for 

any confidential information contained 

therein, may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. Hearing impaired 

individuals are advised that information 

on this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. Persons 

with mobility impairments who will 

need special assistance in gaining access 

to the Commission should contact the 

Office of the Secretary at (202) 205– 

2000. General information concerning 

the Commission may also be obtained 

by accessing its internet server at 

https://www.usitc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Jessica Mullan, Office of the Secretary, 

Docket Services Division, U.S. 

International Trade Commission, 

telephone (202) 205–1802. 

SUPPLEMENTARY INFORMATION: 

Authority: The authority for 

institution of this investigation is 

contained in section 337 of the Tariff 

Act of 1930, as amended, 19 U.S.C. 

1337, and in section 210.10 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10 (2021). 

Scope of Investigation: Having 

considered the complaint, the U.S. 

International Trade Commission, on 

February 24, 2022, ordered that— 

(1) Pursuant to subsection (b) of 

section 337 of the Tariff Act of 1930, as 

amended, an investigation be instituted 

to determine whether there is a 

violation of subsection (a)(1)(B) of 

section 337 in the importation into the 

United States, the sale for importation, 

or the sale within the United States after 

importation of certain products 

identified in paragraph (2) by reason of 

infringement of one or more of claims 

1–17 of the ’392 patent, and whether an 

industry in the United States exists as 

required by subsection (a)(2) of section 

337; 

(2) Pursuant to section 210.10(b)(1) of 

the Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10(b)(1), the 

plain language description of the 

accused products or category of accused 

products, which defines the scope of the 

investigation, is ‘‘products containing 

crystalline modification IV of 

pyraclostrobin and components 

thereof’’; 

(3) For the purpose of the 

investigation so instituted, the following 

are hereby named as parties upon which 

this notice of investigation shall be 

served: 

(a) The complainants are: 

BASF SE, Carl-Bosch-Str. 38, 67056 

Ludwigshafen, Germany 

BASF Corporation, 100 Campus Drive, 

Florham Park, New Jersey 07932 

(b) The respondents are the following 

entities alleged to be in violation of 

section 337, and are the parties upon 

which the complaint is to be served: 

Sharda Cropchem Ltd., Prime Business 

Park, 2nd Floor, Mumbai, 

Maharashtra, 400056, India 

Sharda USA LLC, 34 E, Germantown 

Pike #227, Norristown, PA 19401 

(4) For the investigation so instituted, 

the Chief Administrative Law Judge, 

U.S. International Trade Commission, 

shall designate the presiding 

Administrative Law Judge. 

The Office of Unfair Import 

Investigations will not participate as a 

party in this investigation. 

Responses to the complaint and the 

notice of investigation must be 

submitted by the named respondents in 

accordance with section 210.13 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.13. Pursuant to 

19 CFR 201.16(e) and 210.13(a), as 

amended in 85 FR 15798 (March 19, 

2020), such responses will be 

considered by the Commission if 

received not later than 20 days after the 

date of service by the complainants of 

the complaint and the notice of 

investigation. Extensions of time for 

submitting responses to the complaint 

and the notice of investigation will not 

be granted unless good cause therefor is 

shown. 

Failure of a respondent to file a timely 

response to each allegation in the 

complaint and in this notice may be 

deemed to constitute a waiver of the 

right to appear and contest the 

allegations of the complaint and this 

notice, and to authorize the 

administrative law judge and the 

Commission, without further notice to 

the respondent, to find the facts to be as 

alleged in the complaint and this notice 

and to enter an initial determination 

and a final determination containing 

such findings, and may result in the 

issuance of an exclusion order or a cease 

and desist order or both directed against 

the respondent. 

By order of the Commission. 

Issued: February 24, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–04338 Filed 3–1–22; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–967] 

Bulk Manufacturer of Controlled 

Substances Application: Sterling 

Pharma USA, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Sterling Pharma USA, LLC 

has applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplementary Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before May 2, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

May 2, 2022. 

ADDRESSES: The DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment.’’ 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on January 12, 2022, 

Sterling Pharma USA, LLC, 1001 

Sheldon Drive, Suite 101, Cary, North 

Carolina 27513–2078, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Tetrahydrocannabinols ............. 7370 I 

In reference to drug codes 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture this drug 

exclusively from hemp extract for 

distribution and sale to its customer. No 


lotter on DSK11XQN23PROD with NOTICES1